Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-004042
Filing Date
2020-02-10
Accepted
2020-02-10 16:06:54
Documents
61
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q onvo-10q_20191231.htm 10-Q 1732174
2 EX-31.1 onvo-ex311_7.htm EX-31.1 9480
3 EX-31.2 onvo-ex312_6.htm EX-31.2 9453
4 EX-32.1 onvo-ex321_8.htm EX-32.1 8946
  Complete submission text file 0001564590-20-004042.txt   6234109

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT onvo-20191231.xml EX-101.INS 1182269
6 XBRL TAXONOMY EXTENSION SCHEMA onvo-20191231.xsd EX-101.SCH 52266
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE onvo-20191231_cal.xml EX-101.CAL 31276
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE onvo-20191231_def.xml EX-101.DEF 221412
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE onvo-20191231_lab.xml EX-101.LAB 412807
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE onvo-20191231_pre.xml EX-101.PRE 344574
Mailing Address 6275 NANCY RIDGE DRIVE SUITE 110 SAN DIEGO CA 92121
Business Address 6275 NANCY RIDGE DRIVE SUITE 110 SAN DIEGO CA 92121 858-224-1000
ORGANOVO HOLDINGS, INC. (Filer) CIK: 0001497253 (see all company filings)

EIN.: 271488943 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-35996 | Film No.: 20591934
SIC: 2836 Biological Products, (No Diagnostic Substances)